02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

580A AASLD ABSTRACTS HEPATOLOGY, October, 2015<br />

742<br />

External validation of risk-stratification criteria in variceal<br />

bleeding (ChildC-C1, MELD19) for the optimization<br />

of the use of early TIPS<br />

Salvador Augustin 1 , Juan Abraldes 2 , Lucio Amitrano 3 , Alba<br />

Cachero 4 , Maria Anna Guardascione 3 , Jose Castellote 4 , Puneeta<br />

Tandon 2 , Joan Genescà 1 ; 1 Hospital Universitari Vall d’Hebron,<br />

Barcelona, Spain; 2 University of Alberta, Edmonton, AB, Canada;<br />

3 Ospedale Cardarelli, Naples, Italy; 4 Hospital Bellvitge, Barcelona,<br />

Spain<br />

Early-TIPS is currently considered the treatment of choice for<br />

high-risk cirrhotic patients with acute variceal bleeding (AVB).<br />

However, recent <strong>studies</strong> have shown that the criteria used to<br />

define high-risk should be refined. Several alternatives to early-TIPS<br />

criteria (Child B + active bleeding and Child C) have<br />

been proposed (Child C + creatinine >1 mg/dL, ChildCC1;<br />

and MELD ≥19). The aim of the present study was to evaluate<br />

the external validity of three classification rules (early-TIPS trial<br />

criteria, ChildCC1 and MELD19) to identify high-risk patients<br />

eligible for early-TIPS after an ABV. In the present observational,<br />

retrospective, multicentric, international study, we<br />

reviewed already collected data from 915 patients with AVB<br />

from 4 centers which have previously published <strong>studies</strong> on the<br />

issue (Naples-Italy; Alberta-Canada; Bellvitge and Vall d’Hebron-Spain).<br />

All patients were treated with current standard of<br />

care (drugs + ligation + antibiotics, with TIPS as rescue therapy).<br />

Most patients had viral (39%) or alcohol (35%) cirrhosis<br />

(12% had both). Median age was 59 (range 23-90), 64%<br />

were male. 6-week mortality in the whole cohort was 18%.<br />

Excluding patients non-eligible for TIPS (age ≥75, creatinine<br />

≥3 mg/dL, Child score ≥14, HCC beyond Milano criteria or<br />

portal thrombosis, N=673) mortality was 15%. Mortality for<br />

Child class and each classification rule for these patients are<br />

shown in the table. All 3 rules discriminated well high vs. lowrisk<br />

patients. However, mortality for Child B was significantly<br />

lower than for Child C patients, regardless of active bleeding.<br />

Within Child C, mortality was overall high but significantly<br />

different depending on baseline creatinine (23% in

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!